Breaking News Instant updates and real-time market news.

KKR

KKR

$34.78 /

+0.015 (+0.04%)

06:52
10/30/20
10/30
06:52
10/30/20
06:52

KKR reports Q3 EPS 48c, consensus 40c

Reports Q3 revenue $1.89B, consensus $922.29M.

  • 30

    Oct

KKR KKR
$34.78 /

+0.015 (+0.04%)

08/05/20 Citi
Citi adds KKR to U.S. Focus List, ups price target to $47.50
07/09/20 Keefe Bruyette
KKR price target raised to $41 from $34 at Keefe Bruyette
06/29/20 Wells Fargo
CyrusOne CEO appointment could reignite sale speculation, says Wells Fargo
06/17/20 Piper Sandler
KKR initiated with an Overweight at Piper Sandler

TODAY'S FREE FLY STORIES

Recommendations
Axis Capital price target raised to $65 from $55 at MKM Partners » 08:29
11/27/20
11/27
08:29
11/27/20
08:29
AXS

Axis Capital

$52.64 /

-0.8 (-1.50%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXS Axis Capital
$52.64 /

-0.8 (-1.50%)

AXS Axis Capital
$52.64 /

-0.8 (-1.50%)

11/03/20 Deutsche Bank
Axis Capital price target raised to $44 from $42 at Deutsche Bank
04/01/20 Wells Fargo
Axis Capital price target lowered to $43 from $60 at Wells Fargo
01/06/20 Wells Fargo
Axis Capital downgraded to Underweight at Wells Fargo
01/06/20 Wells Fargo
Axis Capital downgraded to Underweight from Equal Weight at Wells Fargo
AXS Axis Capital
$52.64 /

-0.8 (-1.50%)

AXS Axis Capital
$52.64 /

-0.8 (-1.50%)

Recommendations
Salesforce deal for Slack would likely be dilutive, says Morgan Stanley » 08:26
11/27/20
11/27
08:26
11/27/20
08:26
CRM

Salesforce

$246.75 /

-13.96 (-5.35%)

, WORK

Slack Technologies

$40.71 /

+11.14 (+37.67%)

Commenting on the The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

08:23 Today MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

Recommendations
Facebook, Google may also be interested in Slack, says MKM Partners » 08:23
11/27/20
11/27
08:23
11/27/20
08:23
WORK

Slack Technologies

$40.71 /

+11.14 (+37.67%)

, GOOGL

Alphabet Class A

$1,765.50 /

+1.79 (+0.10%)

, FB

Facebook

$275.54 /

-1.295 (-0.47%)

, AMZN

Amazon.com

$3,185.20 /

+65.2 (+2.09%)

, MSFT

Microsoft

$213.78 /

-0.08 (-0.04%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/03/20 Citi
Alphabet Class A price target raised to $2,000 from $1,600 at Citi
11/02/20 Canaccord
Alphabet price target raised to $1900 from $1800 at Canaccord
FB Facebook
$275.54 /

-1.295 (-0.47%)

10/30/20 Raymond James
Facebook price target raised to $320 from $280 at Raymond James
10/30/20 Canaccord
Facebook price target raised to $330 from $315 at Canaccord
10/30/20 MKM Partners
Facebook price target raised to $330 from $300 at MKM Partners
10/30/20 Wedbush
Facebook price target raised to $320 from $300 at Wedbush
AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
11/23/20 Goldman Sachs
GoodRx price target lowered to $44 from $49 at Goldman Sachs
11/20/20 Credit Suisse
GoodRx price target lowered to $49 from $60 at Credit Suisse
11/19/20 Pivotal Research
Pivotal Research upgrades Roku to Hold with lead seeming sustainable
MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

08:13 Today DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

GOOGL Alphabet Class A
$1,765.50 /

+1.79 (+0.10%)

FB Facebook
$275.54 /

-1.295 (-0.47%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

Recommendations
Salesforce acquisition of Slack would 'make sense', says DA Davidson » 08:13
11/27/20
11/27
08:13
11/27/20
08:13
WORK

Slack Technologies

$40.71 /

+11.14 (+37.67%)

, CRM

Salesforce

$246.75 /

-13.96 (-5.35%)

, AMZN

Amazon.com

$3,185.20 /

+65.2 (+2.09%)

, MSFT

Microsoft

$213.78 /

-0.08 (-0.04%)

DA Davidson analyst Rishi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
CRM Salesforce
$246.75 /

-13.96 (-5.35%)

07:21 Today Needham
Needham 'not enamored' with potential Salesforce acquisition of Slack
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/25/20 BMO Capital
Salesforce price target raised to $285 from $260 at BMO Capital
AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

11/23/20 Goldman Sachs
GoodRx price target lowered to $44 from $49 at Goldman Sachs
11/20/20 Credit Suisse
GoodRx price target lowered to $49 from $60 at Credit Suisse
11/19/20 Pivotal Research
Pivotal Research upgrades Roku to Hold with lead seeming sustainable
11/19/20 Credit Suisse
Credit Suisse remains bullish on Amazon ahead of quarterly results
MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
11/23/20 KeyBanc
Microsoft initiated with an Overweight at KeyBanc
WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

WORK Slack Technologies
$40.71 /

+11.14 (+37.67%)

CRM Salesforce
$246.75 /

-13.96 (-5.35%)

AMZN Amazon.com
$3,185.20 /

+65.2 (+2.09%)

MSFT Microsoft
$213.78 /

-0.08 (-0.04%)

Hot Stocks
Trident Acquisitions Corp. files poxy supplement on business combination » 08:10
11/27/20
11/27
08:10
11/27/20
08:10
TDAC

Trident Acquisitions Corp.

$11.09 /

+0.1 (+0.91%)

Trident Acquisitions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDAC Trident Acquisitions Corp.
$11.09 /

+0.1 (+0.91%)

Syndicate
Allena Pharmaceuticals files to sell 6.1M shares of common stock for holders  08:09
11/27/20
11/27
08:09
11/27/20
08:09
ALNA

Allena Pharmaceuticals

$1.39 /

+0.045 (+3.36%)

 
ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
$1.39 /

+0.045 (+3.36%)

ALNA Allena Pharmaceuticals
$1.39 /

+0.045 (+3.36%)

10/01/20 B. Riley Securities
Allena Pharmaceuticals price target raised to $5 from $4 at B. Riley Securities
06/01/20 H.C. Wainwright
Allena Pharmaceuticals initiated with a Buy at H.C. Wainwright
03/18/20 Roth Capital
Allena Pharmaceuticals price target lowered to $11 from $31 at Roth Capital
02/12/20 Roth Capital
Streamlining makes Allena URIROX-2 path clear, says Roth Capital
ALNA Allena Pharmaceuticals
$1.39 /

+0.045 (+3.36%)

Hot Stocks
Cypress Development announces extension to Nevada option agreement » 08:08
11/27/20
11/27
08:08
11/27/20
08:08
CYDVF

Cypress Development

$0.00 /

+ (+0.00%)

Cypress Development…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYDVF Cypress Development
$0.00 /

+ (+0.00%)

CYDVF Cypress Development
$0.00 /

+ (+0.00%)

Hot Stocks
SmartPharm awarded contract for development of countermeasure against COVID » 08:07
11/27/20
11/27
08:07
11/27/20
08:07
SRNE

Sorrento Therapeutics

$6.89 /

+0.105 (+1.55%)

SmartPharm Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

07/31/20 H.C. Wainwright
Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright
07/20/20 Dawson James
Sorrento antibody cocktail effort could move quickly, says Dawson James
05/26/20 Dawson James
Sorrento Therapeutics initiated with a Buy at Dawson James
SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

SRNE Sorrento Therapeutics
$6.89 /

+0.105 (+1.55%)

Hot Stocks
Scorpio Bulkers announces sale of Ultramax vessels for $67M » 08:05
11/27/20
11/27
08:05
11/27/20
08:05
SALT

Scorpio Bulkers

$16.19 /

+0.16 (+1.00%)

Scorpio Bulkers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SALT Scorpio Bulkers
$16.19 /

+0.16 (+1.00%)

SALT Scorpio Bulkers
$16.19 /

+0.16 (+1.00%)

10/29/20
Scorpio Bulkers participates in a conference call hosted by B. Riley Securities
10/28/20 B. Riley Securities
Scorpio Bulkers price target lowered to $30 from $35 at B. Riley Securities
07/07/20 B. Riley FBR
Scorpio Bulkers price target lowered to $35 from $40 at B. Riley FBR
06/10/20 Stifel
Scorpio Bulkers price target lowered to $33 from $40 at Stifel
SALT Scorpio Bulkers
$16.19 /

+0.16 (+1.00%)

  • 10
    Jun
SALT Scorpio Bulkers
$16.19 /

+0.16 (+1.00%)

Initiation
O3 Mining initiated with a Speculative Buy at Cormark » 08:05
11/27/20
11/27
08:05
11/27/20
08:05
OQMGF

O3 Mining

$0.00 /

+ (+0.00%)

Cormark analyst Brock…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OQMGF O3 Mining
$0.00 /

+ (+0.00%)

OQMGF O3 Mining
$0.00 /

+ (+0.00%)

09/16/20 CIBC
O3 Mining price target raised to C$6 from C$5 at CIBC
09/11/20 National Bank
O3 Mining price target raised to C$4.75 from C$3.50 at National Bank
08/28/20 Canaccord
Canaccord backs Speculative Buy on O3 Mining after Val d'Or results
05/21/20 CIBC
O3 Mining initiated with an Outperformer at CIBC
Hot Stocks
Genetron says HCCscreen selected by NCC, Wuxi for public health initiative » 08:04
11/27/20
11/27
08:04
11/27/20
08:04
GTH

Genetron

$13.30 /

+0.81 (+6.49%)

Genetron Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTH Genetron
$13.30 /

+0.81 (+6.49%)

GTH Genetron
$13.30 /

+0.81 (+6.49%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$13.30 /

+0.81 (+6.49%)

  • 19
    Jun
GTH Genetron
$13.30 /

+0.81 (+6.49%)

Hot Stocks
Exelixis says Takeda receives approval for CABOMETYX in Japan » 08:03
11/27/20
11/27
08:03
11/27/20
08:03
EXEL

Exelixis

$18.74 /

+0.33 (+1.79%)

, TAK

Takeda Pharmaceutical

$17.72 /

+0.115 (+0.65%)

Exelixis (EXEL) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXEL Exelixis
$18.74 /

+0.33 (+1.79%)

TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

EXEL Exelixis
$18.74 /

+0.33 (+1.79%)

10/26/20 Piper Sandler
Exelixis could have successor to Cabometyx with XL092, says Piper Sandler
09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
EXEL Exelixis
$18.74 /

+0.33 (+1.79%)

TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

TAK Takeda Pharmaceutical
$17.72 /

+0.115 (+0.65%)

Hot Stocks
4D pharma files SEC forms to gain Nasdaq listing following Longevity merger » 08:01
11/27/20
11/27
08:01
11/27/20
08:01
LOAC

Longevity Acquisition Corporation

$11.08 /

+0.16 (+1.47%)

4D pharma announces the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOAC Longevity Acquisition Corporation
$11.08 /

+0.16 (+1.47%)

Initiation
Dye & Durham initiated with an Outperform at Raymond James » 08:00
11/27/20
11/27
08:00
11/27/20
08:00
DYNDF

Dye & Durham

$0.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DYNDF Dye & Durham
$0.00 /

+ (+0.00%)

11/11/20 Canaccord
Dye & Durham price target raised to C$30 from C$28 at Canaccord
10/02/20 Scotiabank
Dye & Durham price target raised to C$27 from C$21 at Scotiabank
Options
Moderna call buyer realizes 22% same-day gains » 08:00
11/27/20
11/27
08:00
11/27/20
08:00
MRNA

Moderna

$109.18 /

+10.54 (+10.69%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$109.18 /

+10.54 (+10.69%)

MRNA Moderna
$109.18 /

+10.54 (+10.69%)

07:39 Today Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/25/20 Goldman Sachs
Moderna price target raised to $139 from $107 at Goldman Sachs
11/23/20
Fly Intel: Top five analyst initiations
11/23/20 Wells Fargo
Moderna initiated with an Equal Weight at Wells Fargo
MRNA Moderna
$109.18 /

+10.54 (+10.69%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$109.18 /

+10.54 (+10.69%)

MRNA Moderna
$109.18 /

+10.54 (+10.69%)

MRNA Moderna
$109.18 /

+10.54 (+10.69%)

Recommendations
Clorox point-of-sale data show acceleration, says DA Davidson » 08:00
11/27/20
11/27
08:00
11/27/20
08:00
CLX

Clorox

$200.82 /

+1.21 (+0.61%)

DA Davidson analyst Linda…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLX Clorox
$200.82 /

+1.21 (+0.61%)

CLX Clorox
$200.82 /

+1.21 (+0.61%)

11/03/20 RBC Capital
Clorox price target raised to $221 from $218 at RBC Capital
11/03/20 Deutsche Bank
Clorox price target raised to $227 from $223 at Deutsche Bank
11/03/20 Citi
Clorox price target lowered to $238 from $246 at Citi
10/16/20
Fly Intel: Top five analyst downgrades
CLX Clorox
$200.82 /

+1.21 (+0.61%)

CLX Clorox
$200.82 /

+1.21 (+0.61%)

CLX Clorox
$200.82 /

+1.21 (+0.61%)

CLX Clorox
$200.82 /

+1.21 (+0.61%)

Hot Stocks
Sage Therapeutics trading resumes  08:00
11/27/20
11/27
08:00
11/27/20
08:00
SAGE

Sage Therapeutics

$82.70 /

+2.7 (+3.38%)

 
ShowHide Related Items >><<
SAGE Sage Therapeutics
$82.70 /

+2.7 (+3.38%)

SAGE Sage Therapeutics
$82.70 /

+2.7 (+3.38%)

11/19/20 Oppenheimer
Sage Therapeutics price target raised to $94 from $65 at Oppenheimer
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Morgan Stanley
Morgan Stanley downgrades Sage Therapeutics amid 'reasonable' expectations
11/16/20 Morgan Stanley
Sage Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
SAGE Sage Therapeutics
$82.70 /

+2.7 (+3.38%)

Hot Stocks
Rhythm Pharmaceuticals trading resumes  08:00
11/27/20
11/27
08:00
11/27/20
08:00
RYTM

Rhythm Pharmaceuticals

$24.11 /

+0.99 (+4.28%)

 
ShowHide Related Items >><<
RYTM Rhythm Pharmaceuticals
$24.11 /

+0.99 (+4.28%)

RYTM Rhythm Pharmaceuticals
$24.11 /

+0.99 (+4.28%)

10/26/20 Stifel
Rhythm Pharmaceuticals price target raised to $36 from $31 at Stifel
01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
RYTM Rhythm Pharmaceuticals
$24.11 /

+0.99 (+4.28%)

Recommendations
Deere price target raised to $335 from $263 at Morgan Stanley » 07:56
11/27/20
11/27
07:56
11/27/20
07:56
DE

Deere

$256.69 /

-4.9 (-1.87%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DE Deere
$256.69 /

-4.9 (-1.87%)

DE Deere
$256.69 /

-4.9 (-1.87%)

06:34 Today RBC Capital
Deere price target raised to $280 from $252 at RBC Capital
11/26/20 Goldman Sachs
Deere demand recovery still in early stages, says Goldman Sachs
11/25/20 Baird
Deere price target raised to $300 from $281 at Baird
11/25/20 Baird
Deere shares 'have room' to move over $300 after earnings, says Baird
DE Deere
$256.69 /

-4.9 (-1.87%)

DE Deere
$256.69 /

-4.9 (-1.87%)

DE Deere
$256.69 /

-4.9 (-1.87%)

Recommendations
Community Healthcare price target raised to $50 from $49 at Truist » 07:55
11/27/20
11/27
07:55
11/27/20
07:55
CHCT

Community Healthcare

$44.93 /

-0.9 (-1.96%)

Truist analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHCT Community Healthcare
$44.93 /

-0.9 (-1.96%)

CHCT Community Healthcare
$44.93 /

-0.9 (-1.96%)

11/25/20 Evercore ISI
Community Healthcare upgraded to Outperform from In Line at Evercore ISI
11/05/20 B. Riley Securities
Community Healthcare price target raised to $49 from $47 at B. Riley Securities
09/30/20 Baird
Community Healthcare assumed with an Outperform at Baird
09/09/20 Colliers
Community Healthcare initiated with a Buy at Colliers
CHCT Community Healthcare
$44.93 /

-0.9 (-1.96%)

Recommendations
Cognizant price target raised to $55 from $50 at UBS » 07:53
11/27/20
11/27
07:53
11/27/20
07:53
CTSH

Cognizant

$78.55 /

-0.21 (-0.27%)

UBS analyst Diviya…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTSH Cognizant
$78.55 /

-0.21 (-0.27%)

CTSH Cognizant
$78.55 /

-0.21 (-0.27%)

11/19/20 Goldman Sachs
Cognizant initiated with a Buy at Goldman Sachs
10/29/20 Societe Generale
Cognizant upgraded to Buy from Hold at Societe Generale
10/29/20 Cowen
Cognizant upgraded to Outperform from Market Perform at Cowen
10/13/20 Susquehanna
Cognizant upgraded to Positive at Susquehanna
CTSH Cognizant
$78.55 /

-0.21 (-0.27%)

CTSH Cognizant
$78.55 /

-0.21 (-0.27%)

CTSH Cognizant
$78.55 /

-0.21 (-0.27%)

CTSH Cognizant
$78.55 /

-0.21 (-0.27%)

Recommendations
Medical Properties Trust price target raised to $21 from $20 at Truist » 07:53
11/27/20
11/27
07:53
11/27/20
07:53
MPW

Medical Properties Trust

$19.77 /

-0.015 (-0.08%)

Truist analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MPW Medical Properties Trust
$19.77 /

-0.015 (-0.08%)

MPW Medical Properties Trust
$19.77 /

-0.015 (-0.08%)

09/09/20 Colliers
Medical Properties Trust initiated with a Buy at Colliers
09/01/20 Stifel
Medical Properties Trust resumed with a Buy at Stifel
08/24/20
Fly Intel: Top five analyst upgrades
08/24/20 Mizuho
Mizuho upgrades Medical Properties on to Buy on 'attractive' valuation
MPW Medical Properties Trust
$19.77 /

-0.015 (-0.08%)

MPW Medical Properties Trust
$19.77 /

-0.015 (-0.08%)

Hot Stocks
XP Inc. comments on Itau Unibanco Holding announcement » 07:50
11/27/20
11/27
07:50
11/27/20
07:50
XP

XP Inc.

$41.95 /

+0.03 (+0.07%)

XP commented, following…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XP XP Inc.
$41.95 /

+0.03 (+0.07%)

XP XP Inc.
$41.95 /

+0.03 (+0.07%)

10/16/20
Fly Intel: Top five analyst upgrades
10/16/20 BofA
XP Inc. upgraded to Neutral from Underperform at BofA
10/16/20 BofA
XP Inc. upgraded to Neutral from Underperform at BofA
06/24/20 Credit Suisse
XP Inc. downgraded to Underperform from Neutral at Credit Suisse
XP XP Inc.
$41.95 /

+0.03 (+0.07%)

  • 02
    Jul
  • 11
    Dec
General news
Treasury Market Outlook: equities are mostly firmer in a quiet trade » 07:50
11/27/20
11/27
07:50
11/27/20
07:50

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
TMAC announces extension notice for national security review of Shandong deal » 07:48
11/27/20
11/27
07:48
11/27/20
07:48
TMMFF

TMAC Resources

$0.00 /

+ (+0.00%)

TMAC Resources announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMMFF TMAC Resources
$0.00 /

+ (+0.00%)

05/21/20 National Bank
TMAC Resources rating changed to Tender from Sector Perform at National Bank
05/11/20 TD Securities
TMAC Resources downgraded to Tender from Hold at TD Securities
03/19/20 RBC Capital
TMAC Resources price target lowered to C$1 from C$5 at RBC Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.